John Hinson, MD
Urology · Athens, ALNPI 1144219320
Payments from drug & device makers
Across 32 payments — averaging $20.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Urovant Sciences Inc$95
- Antares Pharma, Inc.$71
- Procept Biorobotics Corporation$70
- Boston Scientific$65
- Rochester Medical Corporation$47
- Pfizer$43
- plus $268 from 10 others
What the payments were for
- Food & beverage$659100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Urovant Sciences Inc | 5 | $95 |
| Antares Pharma, Inc. | 3 | $71 |
| Procept Biorobotics Corporation | 1 | $70 |
| Boston Scientific | 4 | $65 |
| Rochester Medical Corporation | 3 | $47 |
| Pfizer | 2 | $43 |
| Myovant Sciences Inc. | 3 | $42 |
| Urogen Pharma, Inc. | 1 | $31 |
| Sumitomo Pharma America, Inc. | 2 | $30 |
| Coloplast | 2 | $27 |
| ABC Home Medical Supply, Inc. | 1 | $26 |
| Hollister Incorporated | 1 | $26 |
| Olympus America Inc. | 1 | $25 |
| Astellas Pharma US Inc | 1 | $23 |
| Convatec Inc. | 1 | $20 |
| 180 Medical, Inc. | 1 | $19 |
How this compares
$659 in reported general payments places this provider in the 25th percentile of 179 urology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Finasteride | 241 | $4,267 |
| Tamsulosin Hcl | 211 | $4,235 |
| Oxybutynin Chloride | 26 | $289 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 30 | $110 |
| Ciprofloxacin Hcl | 14 | $53 |
| Ondansetron Hcl | 20 | $37 |
Paid to pharmacies, not to this prescriber.
Other urology in Athens
- James McMurrayHuntsville$4.7M
- Vincent BivinsHomewood$1.3M
- Charles WhiteMobile$735K
- Thomas ChiBirmingham$628K
- Charles BuggHomewood$544K
- Charles PeytonBirmingham$543K
- Brian ChristineHomewood$372K
- Austin LutzHomewood$367K
- Joel FunkBirmingham$347K
- Adam BaumgartenBirmingham$347K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.